Dietary flavonoids and the MLL gene: A pathway to infant leukemia?
- 25 April 2000
- journal article
- review article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 97 (9) , 4411-4413
- https://doi.org/10.1073/pnas.97.9.4411
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemiaProceedings of the National Academy of Sciences, 2000
- p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancerMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1999
- Preventing neural tube defects: The importance of periconceptional folic acid supplementsObstetrics & Gynecology, 1998
- Infant Cancer in the U.S.Journal of Pediatric Hematology/Oncology, 1997
- Aetiology of acute leukaemiaThe Lancet, 1997
- Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): A report from the Children's Cancer GroupCancer Causes & Control, 1996
- Analysis of foetal expression sites of human type II DNA topoisomerase α and β mRNAs by in situ hybridisationBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1996
- Infant Leukemia, Topoisomerase II Inhibitors, and the MLL GeneJNCI Journal of the National Cancer Institute, 1994
- Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.Journal of Clinical Investigation, 1994
- In utero rearrangements in the trithorax-related oncogene in infant leukaemiasNature, 1993